From: Inflammation is correlated with severity and outcome of cerebral venous thrombosis
Ā | Poor condition nā=ā39 | Good condition nā=ā56 | P value |
---|---|---|---|
Female (%) | 27/39 (69.23%) | 30/56 (53.57%) | 0.142 |
Male (%) | 12/39 (30.77%) | 26/56 (46.43%) | 0.142 |
Age, years | 37.62āĀ±ā11.67 | 39.84āĀ±ā14.72 | 0.434 |
Serum Hs-CRP (mg/L) | 4.88 (0.86, 20.42) | 3.06 (0.65, 6.74) | 0.194 |
Serum NLR | 3.45 (2.31, 5.29) | 2.45 (1.72, 3.14) | 0.001 |
Serum IL-6 (pg/ml) | 11.87 (6.50, 14.94) | 8.01 (4.98, 14.94) | 0.451 |
CSF IgA (mg/dl) | 0.46 (0.21, 0.90) | 0.38 (0.38, 0.74) | 0.617 |
CSF IgM (mg/dl) | 1.90 (0.60, 3.00) | 0.95 (0.40, 2.02) | 0.005 |
CSF IgG (mg/dl) | 4.16 (1.87, 6.80) | 3.22 (2.29, 4.96) | 0.423 |